N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141175 |
| CAS No | NA |
| Mol.F. | C15H19N7O3 |
| Mol.Wt. | 345.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141176 |
| CAS No | NA |
| Mol.F. | C16H12BrN7O3 |
| Mol.Wt. | 430.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141177 |
| CAS No | NA |
| Mol.F. | C16H13N7O3 |
| Mol.Wt. | 351.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141178 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141179 |
| CAS No | NA |
| Mol.F. | C24H25N9O3 |
| Mol.Wt. | 487.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141180 |
| CAS No | NA |
| Mol.F. | C30H35N9O5 |
| Mol.Wt. | 601.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141181 |
| CAS No | NA |
| Mol.F. | C18H29N3O2 |
| Mol.Wt. | 319.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141182 |
| CAS No | 36966-84-4 |
| Mol.F. | C6H6N2O |
| Mol.Wt. | 122.1 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141183 |
| CAS No | NA |
| Mol.F. | C9H14N2OS |
| Mol.Wt. | 198.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141184 |
| CAS No | 70890-80-1 |
| Mol.F. | C2H2N4O2 |
| Mol.Wt. | 114.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141185 |
| CAS No | NA |
| Mol.F. | C15H9ClN4O4 |
| Mol.Wt. | 344.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141186 |
| CAS No | NA |
| Mol.F. | C18H16N2O3 |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141187 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141188 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141189 |
| CAS No | NA |
| Mol.F. | C14H11N3O3 |
| Mol.Wt. | 269.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141190 |
| CAS No | NA |
| Mol.F. | C14H10N4O5 |
| Mol.Wt. | 314.3 |
| INV STATUS | CUSTOM SYNTHESIS |